•
Neurological Disease – Dementia

Copyright © 2017 Wolters Kluwer • All Rights Reserved
Signs and Symptoms of HIV/AIDS (cont.)
Signs and Symptoms of HIV/AIDS (cont.)
•
Secondary Infections – Pneumocystis carinii,
disseminated herpes simplex

Copyright © 2017 Wolters Kluwer • All Rights Reserved
Drugs Used to Treat HIV/AIDS
Drugs Used to Treat HIV/AIDS
•
Reverse Transcriptase Inhibitors
•
Protease Inhibitors
•
Nucleosides- NNRTI and NRTI
•
Fusion Inhibitors
•
CCR5 Coreceptor Antagonist
•
Integrase Inhibitors

Copyright © 2017 Wolters Kluwer • All Rights Reserved
Non nucleoside /Nucleoside Reverse
Transcriptase Inhibitors
Non nucleoside /Nucleoside Reverse
Transcriptase Inhibitors
•
Indications –
Bind directly to HIV reverse transcriptase
blocking both RNA and DNA dependent DNA polymerase
activities /compete with the naturally occurring nucleosides
•
Pharmacokinetics –
Rapidly absorbed from the GI tract,
except (Didanosine)
metabolized in the liver, excreted in the
urine and feces
•
Contraindications –
Pregnancy and lactation except
zidovudine, Lamivudine and zalcitabine should not be given
together
•
Adverse Reactions –
Headache, nausea, vomiting, rash, chills,
diarrhea, flu-like syndrome of fever, muscle aches and pains
and bone marrow suppression with Zididovine

Copyright © 2017 Wolters Kluwer • All Rights Reserved
Protease Inhibitors
Protease Inhibitors
•
Indications –
Block protease activity within the HIV virus
•
Pharmacokinetics –
Rapidly absorbed in the GI tract,
metabolized in the liver and excreted in urine and feces
•
Contraindications –
Pregnancy and lactation and mild to
moderate hepatic dysfunction
•
Adverse Reactions-
GI effects, changes in liver function,
elevated cholesterol and triglyceride levels may occur as well as
Stevens-Johnson syndrome risk
•
Drug-to-Drug Interactions-
Fosamprenavir, pimozide, rifampin,
triazolam, or midazolam

Copyright © 2017 Wolters Kluwer • All Rights Reserved
Fusion Inhibitors
Fusion Inhibitors
•
Indications –
Prevents the fusion of the virus with the human
cellular membrane
•
Pharmacokinetics –
Given sub-q; metabolized in the liver it is
recycled in the tissues it is not excreted
•
Contraindications –
Use cautiously with lung disease and
pregnancy
•
Adverse Reactions –
Headache, dizziness, myalgia, nausea,
vomiting, and diarrhea
•
Drug-to-Drug Interactions –
No reported drug interactions

Copyright © 2017 Wolters Kluwer • All Rights Reserved
CCR5 Coreceptor Antagonist
CCR5 Coreceptor Antagonist
•
Indications –
Blocks the receptor site on the cell membrane to
which the HIV virus needs to interact to enter the cell
•
Pharmacokinetics –Rapidly absorbed from the GI tract,
metabolized in the liver, and excreted primarily through the
feces
•
Contraindications –Hypersensitivity to any component of the
drug, nursing mothers and liver disease
•
Adverse Reactions – Dizziness and changes in consciousness
•
Drug-to-Drug Interactions –
Increased serum levels and toxicity
when combined with cytochrome P450 CYP3A inhibitors(ketoconazole,
lopinavir/ritonavir, ritonavir, saquinavir, atazanavir, delavirdine


You've reached the end of your free preview.
Want to read all 188 pages?
- Fall '16
- Bacteria, Wolters Kluwer Health, Wolters Kluwer